NCT02496377View on ClinicalTrials.gov

Cross Iron (Comparative Randomized Oral Versus Systemic IRON)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 29, 2014

Primary Completion Date

October 16, 2016

Study Completion Date

October 16, 2016

Conditions
Allogenic TransfusionPerioperative AnaemiaKnee ArthroplastyHip Arthroplasty
Interventions
DRUG

ferrous glycine sulfate Tardyferon

DRUG

Epoetin Alfa

DRUG

ferric carboxymaltose Ferinject

Trial Locations (1)

34295

Hôpital Lapeyronie - Département Anesthésie Réanimation A, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02496377 - Cross Iron (Comparative Randomized Oral Versus Systemic IRON) | Biotech Hunter | Biotech Hunter